Last Posted: Oct 18, 2019
- Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk – current status and future potential
SK Naber et al, JNCI SPectrum, October 17, 2019 - Mathematics should clarify, not obfuscate: an inaccurate and misleading calculation of the cost-effectiveness of preimplantation genetic testing for aneuploidy.
Paulson Richard J et al. Fertility and sterility 2019 111(6) 1113-1114 - Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.
Zhu Ye et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Oct - The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang Yoon-Jung et al. The Medical journal of Australia 2019 Oct - A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Sun Li et al. JAMA oncology 2019 Oct - Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening.
Bower Alexandra et al. Scientific reports 2019 Oct 9(1) 14098 - Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China.
Wei Xiaoxia et al. Clinical drug investigation 2019 Sep - The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing.
GoodSmith Matthew S et al. Diabetes care 2019 Sep - Genome Diagnostics: Novel Strategies for Measuring Value.
Hayeems Robin Z et al. Journal of managed care & specialty pharmacy 2019 Oct 25(10) 1096-1101 - Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong.
Loong Herbert H et al. PharmacoEconomics - open 2019 Sep
.png)
No hay comentarios:
Publicar un comentario